PubRank

Steven R Feldman

Author PubWeight™ 329.37‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Incidence estimate of nonmelanoma skin cancer in the United States, 2006. Arch Dermatol 2010 8.55
2 Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics. J Am Acad Dermatol 2008 3.95
3 Psoriasis is common, carries a substantial burden even when not extensive, and is associated with widespread treatment dissatisfaction. J Investig Dermatol Symp Proc 2004 3.40
4 Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 2003 3.22
5 Epidemiology of psoriatic arthritis in the population of the United States. J Am Acad Dermatol 2005 3.04
6 Adherence, the fourth dimension in the geometry of dermatological treatment. Arch Dermatol 2009 2.91
7 In the United States, blacks and Asian/Pacific Islanders are more likely than whites to seek medical care for atopic dermatitis. Arch Dermatol 2002 2.75
8 The burden of atopic dermatitis: impact on the patient, family, and society. Pediatr Dermatol 2005 2.26
9 A 50% reduction in the Psoriasis Area and Severity Index (PASI 50) is a clinically significant endpoint in the assessment of psoriasis. J Am Acad Dermatol 2004 2.05
10 Guidelines of care for the management of psoriasis and psoriatic arthritis: section 6. Guidelines of care for the treatment of psoriasis and psoriatic arthritis: case-based presentations and evidence-based conclusions. J Am Acad Dermatol 2011 2.03
11 Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 2. Psoriatic arthritis: overview and guidelines of care for treatment with an emphasis on the biologics. J Am Acad Dermatol 2008 1.99
12 Determinants of quality of life in patients with psoriasis: a study from the US population. J Am Acad Dermatol 2004 1.94
13 Guidelines of care for the management of psoriasis and psoriatic arthritis. Section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies. J Am Acad Dermatol 2009 1.94
14 Interleukin-12, interleukin-23, and psoriasis: current prospects. J Am Acad Dermatol 2007 1.76
15 Guidelines of care for the management of psoriasis and psoriatic arthritis: section 4. Guidelines of care for the management and treatment of psoriasis with traditional systemic agents. J Am Acad Dermatol 2009 1.76
16 The prevalence of psoriasis in African Americans: results from a population-based study. J Am Acad Dermatol 2005 1.68
17 Adherence in dermatology: a review of the last 20 years. J Dermatolog Treat 2006 1.64
18 A randomized comparison of continuous vs. intermittent infliximab maintenance regimens over 1 year in the treatment of moderate-to-severe plaque psoriasis. J Am Acad Dermatol 2006 1.59
19 Drug samples in dermatology: special considerations and recommendations for the future. J Am Acad Dermatol 2010 1.55
20 Pyoderma gangrenosum: a review and update on new therapies. J Am Acad Dermatol 2010 1.53
21 Written action plans: potential for improving outcomes in children with atopic dermatitis. J Am Acad Dermatol 2008 1.52
22 Eligibility creep: a cause for placebo group improvement in controlled trials of psoriasis treatments. J Am Acad Dermatol 2007 1.51
23 A randomized controlled pilot study of the effects of an extra office visit on adherence and outcomes in atopic dermatitis. Arch Dermatol 2010 1.50
24 Cost-effectiveness of biologic treatments for psoriasis based on subjective and objective efficacy measures assessed over a 12-week treatment period. J Am Acad Dermatol 2007 1.50
25 UV light abuse as a substance-related disorder: clinical implications. Arch Dermatol 2008 1.48
26 Guidelines of care for the management of psoriasis and psoriatic arthritis: Section 5. Guidelines of care for the treatment of psoriasis with phototherapy and photochemotherapy. J Am Acad Dermatol 2009 1.48
27 Members of the national psoriasis foundation: more extensive disease and better informed about treatment options. Arch Dermatol 2005 1.45
28 Tacrolimus ointment is effective for facial and intertriginous psoriasis. J Am Acad Dermatol 2004 1.45
29 Trends in pediatric psoriasis outpatient health care delivery in the United States. Arch Dermatol 2011 1.44
30 Stealth monitoring of adherence to topical medication: adherence is very poor in children with atopic dermatitis. J Am Acad Dermatol 2006 1.44
31 Hyperpigmentation: an overview of the common afflictions. Dermatol Nurs 2004 1.43
32 Treatment of psoriasis in children: is there a role for antibiotic therapy and tonsillectomy? Pediatr Dermatol 2003 1.43
33 Dermatosis neglecta: a series of case reports and review of other dirty-appearing dermatoses. Dermatol Online J 2006 1.42
34 Cutaneous symptoms of dermatomyositis significantly impact patients' quality of life. J Am Acad Dermatol 2005 1.42
35 Trends in Mohs surgery from 1995 to 2010: an analysis of nationally representative data. Dermatol Surg 2015 1.42
36 How much of a topical agent should be prescribed for children of different sizes? J Dermatolog Treat 2006 1.40
37 Induction of withdrawal-like symptoms in a small randomized, controlled trial of opioid blockade in frequent tanners. J Am Acad Dermatol 2006 1.40
38 Adherence with topical treatment is poor compared with adherence with oral agents: implications for effective clinical use of topical agents. J Am Acad Dermatol 2006 1.40
39 Where did current academic dermatologists train? J Am Acad Dermatol 2010 1.39
40 Increase in procedures performed at dermatology office visits from 1995 to 2001. Dermatol Surg 2005 1.39
41 Phototherapy trends in dermatology. J Dermatolog Treat 2013 1.38
42 Use of electronic medical records differs by specialty and office settings. J Am Med Inform Assoc 2013 1.34
43 Poor adherence to treatments: a fundamental principle of dermatology. Arch Dermatol 2007 1.34
44 Extended efalizumab therapy improves chronic plaque psoriasis: results from a randomized phase III trial. J Am Acad Dermatol 2005 1.34
45 Quality of life in patients with psoriasis. Health Qual Life Outcomes 2006 1.31
46 Patients with psoriasis prefer solution and foam vehicles: a quantitative assessment of vehicle preference. Cutis 2002 1.27
47 The safety of liposuction: results of a national survey. Dermatol Surg 2002 1.25
48 Pharmacoeconomic considerations in treating actinic keratosis. Pharmacoeconomics 2009 1.24
49 Optimizing topical therapies for treating psoriasis: a consensus conference. Cutis 2010 1.22
50 The economic impact of non-melanoma skin cancer: a review. J Natl Compr Canc Netw 2010 1.20
51 The effect of reminder systems on patients' adherence to treatment. Patient Prefer Adherence 2012 1.19
52 Health care utilization in patients with migraine: demographics and patterns of care in the ambulatory setting. Headache 2003 1.19
53 Tanning as an addictive behavior: a literature review. Photodermatol Photoimmunol Photomed 2009 1.19
54 Correlates of patient satisfaction with physician visit: differences between elderly and non-elderly survey respondents. Health Qual Life Outcomes 2007 1.18
55 Adherence to topical therapy decreases during the course of an 8-week psoriasis clinical trial: commonly used methods of measuring adherence to topical therapy overestimate actual use. J Am Acad Dermatol 2004 1.17
56 What specialties perform the most common outpatient cosmetic procedures in the United States? Dermatol Surg 2007 1.17
57 Traditional systemic treatments have not fully met the needs of psoriasis patients: results from a national survey. J Am Acad Dermatol 2005 1.16
58 Medical adherence to acne therapy: a systematic review. Am J Clin Dermatol 2014 1.15
59 The comorbid state of psoriasis patients in a university dermatology practice. J Dermatolog Treat 2005 1.14
60 A review of targeted ultraviolet B phototherapy for psoriasis. J Am Acad Dermatol 2011 1.12
61 Ustekinumab significantly improves symptoms of anxiety, depression, and skin-related quality of life in patients with moderate-to-severe psoriasis: Results from a randomized, double-blind, placebo-controlled phase III trial. J Am Acad Dermatol 2010 1.10
62 Lower adverse event and mortality rates in physician offices compared with ambulatory surgery centers: a reappraisal of Florida adverse event data. Dermatol Surg 2004 1.09
63 Cost-effectiveness of moderate-to-severe psoriasis treatment. Expert Opin Pharmacother 2006 1.08
64 Tangential shave removal of basal cell carcinoma. Dermatol Surg 2013 1.08
65 Top dermatologic conditions in patients of color: an analysis of nationally representative data. J Drugs Dermatol 2012 1.08
66 A pharmacoeconomic analysis of severe psoriasis therapy: a review of treatment choices and cost efficiency. Expert Opin Pharmacother 2011 1.08
67 Alopecia in the United States: outpatient utilization and common prescribing patterns. J Am Acad Dermatol 2007 1.08
68 Frequency and cost of actinic keratosis treatment. Dermatol Surg 2006 1.07
69 Definitions of measures of effect duration for psoriasis treatments. Arch Dermatol 2005 1.07
70 Acne in adolescents: quality of life, self-esteem, mood, and psychological disorders. Dermatol Online J 2011 1.06
71 Consensus guidelines for the management of plaque psoriasis. Arch Dermatol 2012 1.06
72 Psoriasis and pregnancy. J Cutan Med Surg 2002 1.05
73 Comparative efficacy of biologics in psoriasis: a review. Am J Clin Dermatol 2012 1.03
74 Pachydermodactyly from repetitive motion in poultry processing workers: a report of 2 cases. Arch Dermatol 2012 1.03
75 American Academy of Dermatology Consensus Conference on the safe and optimal use of isotretinoin: summary and recommendations. J Am Acad Dermatol 2004 1.03
76 Combination therapy to treat moderate to severe psoriasis. J Am Acad Dermatol 2004 1.03
77 The negative impact of psoriasis on the workplace. J Dermatolog Treat 2006 1.03
78 A Simplified Psoriasis Area Severity Index (SPASI) for rating psoriasis severity in clinic patients. Dermatol Online J 2004 1.02
79 Acne vulgaris and depression: a retrospective examination. J Cosmet Dermatol 2010 1.01
80 Melasma and its impact on health-related quality of life in Hispanic women. J Dermatolog Treat 2007 1.00
81 Vision problems, eye care history, and ocular protection among migrant farmworkers. Arch Environ Occup Health 2008 1.00
82 What is the best approach to reducing birth defects associated with isotretinoin? PLoS Med 2006 0.99
83 Benzoyl peroxide: a review of its current use in the treatment of acne vulgaris. Expert Opin Pharmacother 2009 0.98
84 Using Hawthorne effects to improve adherence in clinical practice: lessons from clinical trials. JAMA Dermatol 2013 0.98
85 Correlates of health-related quality of life in women with severe facial blemishes. Int J Dermatol 2006 0.98
86 Hyperpigmentation: a review of common treatment options. J Drugs Dermatol 2004 0.97
87 Treatment patterns and cost of nonmelanoma skin cancer management. Dermatol Surg 2006 0.97
88 Nonmelanoma skin cancer: an episode of care management approach. Dermatol Surg 2003 0.96
89 Psoralen plus ultraviolet A light phototherapy effectiveness. J Am Acad Dermatol 2010 0.96
90 Acne vulgaris in the United States: a descriptive epidemiology. Cutis 2010 0.95
91 Patients with palmoplantar psoriasis have more physical disability and discomfort than patients with other forms of psoriasis: implications for clinical practice. J Am Acad Dermatol 2003 0.94
92 Effect of patient satisfaction on outcomes of care. Expert Rev Pharmacoecon Outcomes Res 2009 0.94
93 Seasonal variation of dermatologic disease in the USA: a study of office visits from 1990 to 1998. Int J Dermatol 2004 0.94
94 Side effects of common acne treatments. Expert Opin Drug Saf 2012 0.94
95 Ultraviolet tanning addiction. Dermatol Clin 2009 0.94
96 Topical drug delivery systems in dermatology: a review of patient adherence issues. Expert Opin Drug Deliv 2012 0.94
97 The 5-point Investigator's Global Assessment (IGA) Scale: A modified tool for evaluating plaque psoriasis severity in clinical trials. J Dermatolog Treat 2013 0.94
98 Acitretin in dermatology: a review. J Drugs Dermatol 2011 0.93
99 Nonmelanoma skin cancer: is the incidence really increasing among patients younger than 40? A reexamination using 25 years of U.S. outpatient data. Dermatol Surg 2006 0.93
100 Adverse event reporting: lessons learned from 4 years of Florida office data. Dermatol Surg 2005 0.93
101 A survey of office visits for actinic keratosis as reported by NAMCS, 1990-1999. National Ambulatory Medical Care Survey. Cutis 2002 0.92
102 Factors affecting sleep quality in patients with psoriasis. J Am Acad Dermatol 2009 0.92
103 The cost-effectiveness and cost of treatment failures associated with systemic psoriasis therapies. J Dermatolog Treat 2006 0.92
104 Tanning and skin cancer. Pediatr Dermatol 2005 0.92
105 Top dermatologic diagnoses by age. Dermatol Online J 2014 0.91
106 Medication adherence and health care costs associated with biologics in Medicaid-enrolled patients with psoriasis. J Dermatolog Treat 2006 0.91
107 Latino farmworker perceptions of the risk factors for occupational skin disease. Am J Ind Med 2006 0.91
108 Green tobacco sickness and skin integrity among migrant Latino farmworkers. Am J Ind Med 2008 0.91
109 Understanding and improving treatment adherence in pediatric patients. Semin Cutan Med Surg 2010 0.91
110 The Acne Quality of Life Index (Acne-QOLI): development and validation of a brief instrument. Am J Clin Dermatol 2006 0.91
111 Prevalence of pigmentary disorders and their impact on quality of life: a prospective cohort study. J Cosmet Dermatol 2008 0.90
112 Adherence to a topical regimen of 5-fluorouracil, 0.5%, cream for the treatment of actinic keratoses. Arch Dermatol 2009 0.89
113 Self report of skin problems among farmworkers in North Carolina. Am J Ind Med 2008 0.89
114 A systematic review of adverse effects associated with topical treatments for psoriasis. Dermatol Online J 2003 0.89
115 Recruiting underserved populations to dermatologic research: a systematic review. Int J Dermatol 2011 0.89
116 Healthcare utilization for acute and chronic diseases of young, school-age children in the rural and non-rural setting. Clin Pediatr (Phila) 2005 0.89
117 Adverse events from systemic therapies for psoriasis are common in clinical practice. J Dermatolog Treat 2006 0.89
118 The association of skin conditions with housing conditions among North Carolina Latino migrant farm workers. Int J Dermatol 2013 0.89
119 A randomized controlled pilot study of strategies to increase adherence in teenagers with acne vulgaris. J Am Acad Dermatol 2011 0.88
120 Electronic monitoring of medication adherence in skin disease: results of a pilot study. J Am Acad Dermatol 2003 0.88
121 Assessing adherence to dermatology treatments: a review of self-report and electronic measures. Skin Res Technol 2010 0.88
122 Simplifying regimens promotes greater adherence and outcomes with topical acne medications: a randomized controlled trial. Cutis 2010 0.88
123 The prevalence of melasma and its association with quality of life in adult male Latino migrant workers. Int J Dermatol 2009 0.88
124 A review of phototherapy protocols for psoriasis treatment. J Am Acad Dermatol 2011 0.87
125 Patient demographics and utilization of health care services for molluscum contagiosum. Pediatr Dermatol 2004 0.87
126 The safety of office-based surgery: review of recent literature from several disciplines. Arch Dermatol 2004 0.87
127 Predictors of treatment choices and associated outcomes in actinic keratoses: results from a national physician survey study. J Dermatolog Treat 2006 0.87
128 Physicians' perceptions of an eczema action plan for atopic dermatitis. J Dermatolog Treat 2010 0.87
129 Current and future evidence-based acne treatment: a review. Expert Opin Pharmacother 2013 0.87
130 Good adherence and early efficacy using desonide hydrogel for atopic dermatitis: results from a program addressing patient compliance. J Drugs Dermatol 2010 0.87
131 Incidence, risk factors, and preventative management of skin cancers in organ transplant recipients: a review of single- and multicenter retrospective studies from 2006 to 2010. Dermatol Surg 2012 0.87
132 Safety and tolerability of tumor necrosis factor-α inhibitors in psoriasis: a narrative review. Am J Clin Dermatol 2014 0.87
133 Statistical significance and clinical relevance: the importance of power in clinical trials in dermatology. Arch Dermatol 2004 0.86
134 How PAs improve access to care for the underserved. JAAPA 2007 0.86
135 Advancement in benzoyl peroxide-based acne treatment: methods to increase both efficacy and tolerability. J Drugs Dermatol 2009 0.86
136 Quality of life measures for acne patients. Dermatol Clin 2011 0.86
137 The effect of folate supplementation on methotrexate efficacy and toxicity in psoriasis patients and folic acid use by dermatologists in the USA. Am J Clin Dermatol 2013 0.86
138 Treating skin disease: self-management behaviors of Latino farmworkers. J Agromedicine 2006 0.86
139 Diagnostic codes associated with hypnotic medications during outpatient physician-patient encounters in the United States from 1990-1998. Sleep 2002 0.86
140 Analysis of NAMCS data for multiple sclerosis, 1998-2004. BMC Med 2007 0.86
141 A review of home phototherapy for psoriasis. Dermatol Online J 2010 0.86
142 Immunogenicity of biologic treatments for psoriasis: therapeutic consequences and the potential value of concomitant methotrexate. Am J Clin Dermatol 2015 0.86
143 Interleukin-23 and interleukin-17: importance in pathogenesis and therapy of psoriasis. Dermatol Online J 2012 0.85
144 Medication adherence, healthcare costs and utilization associated with acne drugs in Medicaid enrollees with acne vulgaris. Am J Clin Dermatol 2013 0.85
145 Does cost-effectiveness play a role in clinical trials? Dermatol Ther 2007 0.85
146 Trends in the treatment of acne vulgaris: are measures being taken to avoid antimicrobial resistance? J Drugs Dermatol 2010 0.85
147 Improvement in treatment adherence with a 3-day course of fluocinonide cream 0.1% for atopic dermatitis. Cutis 2010 0.85
148 Sleep disturbances in psoriasis. Dermatol Online J 2013 0.85
149 Infections associated with the use of tumor necrosis factor-α inhibitors in psoriasis. J Drugs Dermatol 2013 0.85
150 Risk of cardiovascular disorders in psoriasis patients: current and future. Am J Clin Dermatol 2013 0.84
151 The cost-effectiveness of rosacea treatments. J Dermatolog Treat 2009 0.84
152 Are there racial and sex differences in the use of oral isotretinoin for acne management in the United States? J Am Acad Dermatol 2003 0.84
153 Dermatological illnesses of immigrant poultry-processing workers in North Carolina. Arch Environ Occup Health 2006 0.84
154 Trends in prescription of acne medication in the US: shift from antibiotic to non-antibiotic treatment. J Dermatolog Treat 2005 0.84
155 Plasma beta-endorphin levels in frequent and infrequent tanners before and after ultraviolet and non-ultraviolet stimuli. J Am Acad Dermatol 2006 0.84
156 The promise and challenge of new biological treatments for psoriasis: how do they impact quality of life? Dermatol Ther 2004 0.83
157 The role of tetracyclines in rosacea. Am J Clin Dermatol 2010 0.83
158 Pterygium among Latino migrant farmworkers in North Carolina. Arch Environ Occup Health 2007 0.83
159 Cutaneous lupus erythematosus simulating squamous neoplasia: the clinicopathologic conundrum and histopathologic pitfalls. J Am Acad Dermatol 2007 0.83
160 The cost of psoriasis therapies: considerations for therapy selection. Dermatol Nurs 2004 0.83
161 Comparison of skin concentrations following topical versus oral corticosteroid treatment: reconsidering the treatment of common inflammatory dermatoses. J Drugs Dermatol 2009 0.83
162 JAK inhibitors in psoriasis: a promising new treatment modality. J Drugs Dermatol 2012 0.83
163 Conversations on psoriasis--what patients want and what physicians can provide: a qualitative look at patient and physician expectations. J Dermatolog Treat 2010 0.83
164 Topical tacrolimus ointment combined with 6% salicylic acid gel for plaque psoriasis treatment. Arch Dermatol 2005 0.83
165 The skinny on psoriasis and obesity. Arch Dermatol 2005 0.83
166 Adherence to clocortolone pivalate cream 0.1% in a pediatric population with atopic dermatitis. Cutis 2008 0.83
167 Treatment of Becker nevus with topical flutamide. J Am Acad Dermatol 2013 0.83
168 Contact dermatitis in tobacco farmworkers. Contact Dermatitis 2007 0.83
169 Cost effectiveness of biologic therapies for plaque psoriasis. Am J Clin Dermatol 2013 0.83
170 Capitation payment, length of visit, and preventive services: evidence from a national sample of outpatient physicians. Am J Manag Care 2002 0.83
171 An open label study of clobetasol propionate 0.05% and betamethasone valerate 0.12% foams in the treatment of mild to moderate acne keloidalis. Cutis 2005 0.83
172 The quality of life impact of acne and rosacea compared to other major medical conditions. J Drugs Dermatol 2014 0.83
173 How good are US dermatologists at discriminating skin cancers? A number-needed-to-treat analysis. J Dermatolog Treat 2011 0.82
174 Novel combination regimens: biologics and acitretin for the treatment of psoriasis-- a case series. J Dermatolog Treat 2006 0.82
175 Changing age of acne vulgaris visits: another sign of earlier puberty? Pediatr Dermatol 2011 0.82
176 Medication adherence among acne patients: a review. J Cosmet Dermatol 2010 0.82
177 Surgery for basal-cell carcinoma of the face. Lancet 2004 0.82
178 Systemic therapies for psoriasis: an evidence-based update. Am J Clin Dermatol 2014 0.82
179 An exploratory study of adherence to topical benzoyl peroxide in patients with acne vulgaris. J Am Acad Dermatol 2009 0.82
180 Cost per responder analysis of ustekinumab and etanercept for moderate to severe plaque psoriasis. J Dermatolog Treat 2011 0.82
181 Pediatricians who prescribe clotrimazole-betamethasone diproprionate (Lotrisone) often utilize it in inappropriate settings regardless of their knowledge of the drug's potency. Dermatol Online J 2002 0.82
182 Phototherapy utilization for psoriasis is declining in the United States. J Am Acad Dermatol 2002 0.82
183 Adherence to adalimumab in patients with moderate to severe psoriasis. Dermatol Online J 2013 0.82
184 The impact of biologics on the quality of life of psoriasis patients and the economics of psoriasis care. Semin Cutan Med Surg 2005 0.81
185 A randomized, double-blind, placebo-controlled study of clobetasol propionate 0.05% foam in the treatment of nonscalp psoriasis. Int J Dermatol 2002 0.81
186 Measures used in specifying psoriasis lesion(s), global disease and quality of life: a systematic review. J Dermatolog Treat 2007 0.81
187 The economic burden of skin disease in the United States. J Am Acad Dermatol 2003 0.81
188 The prevalence and possible causes of contact dermatitis in farmworkers. Int J Dermatol 2009 0.81
189 An Internet-based survey and improvement of acne treatment outcomes. Arch Dermatol 2011 0.81
190 The pharmacoeconomics of acne treatment: where are we heading? J Dermatolog Treat 2008 0.81
191 Skin-related quality of life among migrant farmworkers. J Cutan Med Surg 2008 0.81
192 The family impact of atopic dermatitis in children: the role of the parent caregiver. Pediatr Dermatol 2003 0.81
193 Home narrowband UV-B phototherapy in combination with low-dose acitretin in patients with moderate to severe psoriasis. Arch Dermatol 2008 0.81
194 Do utilization management controls for phototherapy increase the prescription of biologics? J Dermatolog Treat 2006 0.81
195 Imiquimod: a review of basal cell carcinoma treatments. J Drugs Dermatol 2008 0.81
196 The association of dermatologist-diagnosed and self-reported skin diseases with skin-related quality of life in Latino migrant farmworkers. Int J Dermatol 2008 0.81
197 Clinical diagnosis of actinic keratosis identifies an elderly population at high risk of developing skin cancer. Dermatol Surg 2005 0.81
198 Adherence to ustekinumab in psoriasis patients. J Drugs Dermatol 2013 0.81
199 Dermatologists' knowledge of and preferences regarding topical steroids. J Drugs Dermatol 2013 0.81
200 Patterns of ambulatory care usage and leading treatments for rosacea. J Dermatolog Treat 2014 0.80
201 Combination therapy for psoriasis in the United States. J Drugs Dermatol 2013 0.80
202 Clobetasol propionate lotion, an efficient and safe alternative to clobetasol propionate emollient cream in subjects with moderate to severe plaque-type psoriasis. J Dermatolog Treat 2005 0.80
203 Prescribing patterns for topical retinoids: analyses of 15 years of data from the national ambulatory medical care survey. J Dermatolog Treat 2010 0.80
204 The Relationship Between Physician Friendliness and Caring, and Patient Satisfaction: Findings from an Internet-Based Survey. Patient 2008 0.80
205 Psoriasis treatment in the United States at the end of the 20th century. Int J Dermatol 2006 0.80
206 How Frequency of Electrosurgical Current and Electrode Size Affect the Depth of Electrocoagulation. Dermatol Surg 2016 0.80
207 Patients' educational needs about topical treatments for psoriasis. J Am Acad Dermatol 2012 0.80
208 Frequency of seborrheic keratosis biopsies in the United States: a benchmark of skin lesion care quality and cost effectiveness. Dermatol Surg 2003 0.80
209 Letter: Treatment-resistant pyoderma gangrenosum. Dermatol Online J 2012 0.80
210 Dermatologic disease in family medicine. Fam Med 2008 0.80
211 Side effects of naltrexone observed in frequent tanners: could frequent tanners have ultraviolet-induced high opioid levels? J Am Acad Dermatol 2005 0.80
212 Analysis of factors associated with increased prescription illegibility: results from the National Ambulatory Medical Care Survey, 1990-1998. Am J Manag Care 2003 0.80
213 Combination therapy in psoriasis: an evidence-based review. Am J Clin Dermatol 2013 0.80
214 Estimating the time required for a complete skin examination. J Am Acad Dermatol 2010 0.80
215 Corrective cosmetics are effective for women with facial pigmentary disorders. Cutis 2005 0.80
216 Comparing the lifetime risks of TNF-alpha inhibitor use to common benchmarks of risk. J Dermatolog Treat 2011 0.80
217 Most people with psoriasis or rosacea are not being treated: a large population study. Dermatol Online J 2016 0.80
218 Underuse of early follow-up visits: a missed opportunity to improve patients' adherence. J Drugs Dermatol 2014 0.79
219 Treatment of preadolescent acne in the United States: an analysis of nationally representative data. Pediatr Dermatol 2013 0.79
220 Differences in acne treatment prescribing patterns of pediatricians and dermatologists: an analysis of nationally representative data. Pediatr Dermatol 2008 0.79
221 Incidence rates, costs, severity, and work-related factors of occupational dermatitis: a workers' compensation analysis of Oregon, 1990-1997. Arch Dermatol 2005 0.79
222 Patterns of vitamin D analog use for the treatment of psoriasis. J Drugs Dermatol 2013 0.79
223 Surgical treatment of nonmelanoma skin cancer in the Medicare population. Dermatol Surg 2003 0.79
224 Characteristics of office-based physician visits for cutaneous fungal infections. an analysis of 1990 to 1994 National Ambulatory Medical Care Survey Data. Cutis 2002 0.79
225 Rosacea: new and emerging treatments. Drugs 2014 0.79
226 Topical tacrolimus 0.1% improves symptoms of hand dermatitis in patients treated with a prednisone taper. J Drugs Dermatol 2008 0.79
227 Paradoxical effects of cost reduction measures in managed care systems for treatment of severe psoriasis. Dermatol Online J 2009 0.79
228 Psoriasis treatment 2003 at the new millennium: position paper on behalf of the authors. J Am Acad Dermatol 2003 0.79
229 Maternal adherence factors in the treatment of pediatric atopic dermatitis. JAMA Dermatol 2013 0.79
230 Trends in the outpatient medication management of lupus erythematosus in the United States. J Drugs Dermatol 2014 0.79
231 Calcitriol ointment: a review of a topical vitamin D analog for psoriasis. J Dermatolog Treat 2009 0.79
232 Why are there differences in the perceived safety of office-based surgery? Dermatol Surg 2004 0.79
233 Open label trial of alefacept in palmoplantar pustular psoriasis. J Dermatolog Treat 2008 0.79
234 Practice trends in the treatment of actinic keratosis in the United States: 0.5% fluorouracil and combination cryotherapy plus fluorouracil are underused despite evidence of benefit. J Cutan Med Surg 2012 0.79
235 Medication choice and associated health care outcomes and costs for patients with acne and acne-related conditions in the United States. J Drugs Dermatol 2011 0.79
236 Self-treatment with bleach by a Latino farmworker. Dermatitis 2008 0.79
237 Use of St. John's Wort in potentially dangerous combinations. J Altern Complement Med 2014 0.79
238 Podcasting in dermatology education. J Dermatolog Treat 2010 0.78
239 Quality of dermatologic care delivered by physician assistants: an analysis of prescribing behavior for the combination antifungal agent clotrimazole-betamethasone. Arch Dermatol 2007 0.78
240 Cell phone allergic contact dermatitis: case report and review. Dermatol Online J 2010 0.78
241 Medication and health care service utilization related to depressive symptoms in older adults with psoriasis. J Drugs Dermatol 2004 0.78
242 Pilot study of the effect of ultraviolet light on pain and mood in fibromyalgia syndrome. J Altern Complement Med 2009 0.78
243 Patients' satisfaction with dermatology residents. South Med J 2012 0.78
244 A review of protocols for 308 nm excimer laser phototherapy in psoriasis. J Drugs Dermatol 2012 0.78
245 New treatments for psoriasis: which biologic is best? J Dermatolog Treat 2006 0.78
246 Critical factors determining the potency of topical corticosteroids. J Dermatolog Treat 2006 0.78
247 Medication-related factors affecting health care outcomes and costs for patients with psoriasis in the United States. J Am Acad Dermatol 2005 0.78
248 Pilot randomized-control trial to assess the effect product sampling has on adherence using adapalene/benzoyl peroxide gel in acne patients. J Drugs Dermatol 2014 0.78
249 Cost-effectiveness of a hydroquinone/tretinoin/fluocinolone acetonide cream combination in treating melasma in the United States. J Dermatolog Treat 2010 0.78
250 Does the teratogenicity of isotretinoin outweigh its benefits? J Dermatolog Treat 2005 0.78
251 Death from psoriasis: representative US data. J Dermatolog Treat 2006 0.78
252 Use of topical antibiotics as prophylaxis in clean dermatologic procedures. J Am Acad Dermatol 2011 0.78
253 Poor compliance with topical corticosteroids for atopic dermatitis despite severe disease. Dermatol Online J 2008 0.78
254 Calcipotriene 0.005%--betamethasone dipropionate 0.064% ointment versus topical suspension in the treatment of plaque psoriasis: a randomized pilot study of patient preference. Cutis 2014 0.78
255 Therapeutic modalities for localized psoriasis: 308-nm UVB excimer laser versus nontargeted phototherapy. Cutis 2012 0.78
256 Prescription refills and healthcare costs associated with topical metronidazole in Medicaid enrolled patients with rosacea. J Dermatolog Treat 2008 0.78
257 Randomized Pilot Clinical Trial of Tofacitinib Solution for Plaque Psoriasis: Challenges of the Intra-Subject Study Design. J Drugs Dermatol 2015 0.77
258 The importance of skin disease as assessed by "willingness-to-pay". J Cutan Med Surg 2003 0.77
259 Would elimination of copayments for phototherapy decrease the cost of treating psoriasis with systemic biologics? A cost analysis. Manag Care Interface 2006 0.77
260 Trends in older adult psoriasis outpatient health care practices in the United States. J Drugs Dermatol 2012 0.77
261 Continued use of home narrowband ultraviolet B light phototherapy for psoriasis after completion of a clinical trial. J Am Acad Dermatol 2009 0.77
262 Sticker charts: a method for improving adherence to treatment of chronic diseases in children. Pediatr Dermatol 2012 0.77
263 Interpretation of dermatopathology specimens is within the standard of care of dermatology practice. Dermatol Surg 2005 0.77
264 Inpatient management of severe psoriasis. J Drugs Dermatol 2005 0.77
265 To test or not to test? An evidence-based assessment of the value of screening and monitoring tests when using systemic biologic agents to treat psoriasis. J Am Acad Dermatol 2008 0.77
266 Tachyphylaxis to topical glucocorticoids; what is the evidence? Dermatol Online J 2013 0.77
267 A review of adapalene in the treatment of acne vulgaris. J Adolesc Health 2008 0.77
268 Rheumatologists' recommendations on what to do in the dermatology office to evaluate and manage psoriasis patients' joint symptoms. J Dermatolog Treat 2009 0.77
269 Adherence to acitretin and home narrowband ultraviolet B phototherapy in patients with psoriasis. J Am Acad Dermatol 2008 0.77
270 A role for denial in poor adherence to psoriasis treatment. J Dermatolog Treat 2007 0.77
271 Cosmetic procedures performed in the United States: a 16-year analysis. Dermatol Surg 2013 0.77
272 Retinoid plus antimicrobial combination treatments for acne. Clin Cosmet Investig Dermatol 2011 0.77
273 The duration of office visits in the United States, 1993 to 2010. Am J Manag Care 2014 0.77
274 Understanding the influence of social media in medicine: lesson learned from Facebook. Dermatol Online J 2014 0.77
275 Topical antibiotic monotherapy prescribing practices in acne vulgaris. J Dermatolog Treat 2014 0.77
276 Predictors of healthcare outcomes and costs related to medication use in patients with acne in the United States. Cutis 2006 0.77
277 Do topical retinoids cause acne to "flare"? J Drugs Dermatol 2009 0.77
278 Insight into psoriasis management: commercial perspectives for the U.S. psoriasis market. J Dermatolog Treat 2010 0.77
279 Complementary and alternative medicine use in dermatology in the United States. J Altern Complement Med 2014 0.77
280 Clobetasol propionate for psoriasis: are ointments really more potent? J Drugs Dermatol 2006 0.77
281 A review of the use of tanning beds as a dermatological treatment. Dermatol Ther (Heidelb) 2015 0.77
282 Combined oral contraceptives for the treatment of acne: a practical guide. Cutis 2012 0.77
283 Methotrexate: understanding the risk in psoriasis patients. J Dermatolog Treat 2009 0.77
284 Social sensitivity and acne: the role of personality in negative social consequences and quality of life. Int J Psychiatry Med 2006 0.77
285 Home ultraviolet B phototherapy: a cost-effective option for severe psoriasis. Manag Care Interface 2006 0.77
286 The prime directive for enhancing patients' medical experience. J Dermatolog Treat 2010 0.77
287 Trends in home phototherapy adoption in the US: monetary disincentives are only the tip of the iceberg. J Dermatolog Treat 2010 0.77
288 Vitamin E and allergic contact dermatitis. Dermatitis 2010 0.77
289 Trends in systemic psoriasis treatment therapies from 1993 through 2010. J Drugs Dermatol 2014 0.77
290 Treatment of Alopecia Areata in the United States: A Retrospective Cross-Sectional Study. J Drugs Dermatol 2015 0.76
291 Management of keloids in the United States, 1990-2009: an analysis of the National Ambulatory Medical Care Survey. Dermatol Surg 2013 0.76
292 Prior authorization for topical psoriasis treatments: is it cost-beneficial for managed care? J Dermatolog Treat 2010 0.76
293 Increasing use of more potent treatments for psoriasis. J Am Acad Dermatol 2008 0.76
294 The cutaneous surgery experience of multiple specialties in the Medicare population. J Am Acad Dermatol 2005 0.76
295 Systematic selection bias: a cause of dramatic errors in the inference of treatment effectiveness. J Dermatolog Treat 2008 0.76
296 The use of 0.25% zinc pyrithione spray does not enhance the efficacy of clobetasol propionate 0.05% foam in the treatment of psoriasis. J Am Acad Dermatol 2003 0.76
297 Self-reported skin symptoms and skin-related quality of life among Latino immigrant poultry processing and other manual workers. Am J Ind Med 2013 0.76
298 Commentary: psoriasis patients with a history of malignancy represent an important but overlooked study population. Dermatol Online J 2011 0.76
299 The compliance pyramid. J Dermatolog Treat 2011 0.76
300 Frictional lichenified dermatosis from prolonged use of a computer mouse: Case report and review of the literature of computer-related dermatoses. Dermatol Online J 2010 0.76
301 Efficacy and safety of ustekinumab and etanercept for the treatment of psoriasis. Expert Opin Biol Ther 2010 0.76
302 Visual discrimination testing of ultraviolet transmitting and ultraviolet blocking acrylic thermoplastics. Photodermatol Photoimmunol Photomed 2002 0.76
303 Tolerability of topical antimicrobials in treatment of acne vulgaris. J Drugs Dermatol 2014 0.76
304 A double-blind, randomized clinical trial of 20% alpha/poly hydroxy acid cream to reduce scaling of lesions associated with moderate, chronic plaque psoriasis. J Drugs Dermatol 2013 0.76
305 Bilateral chondrodermatitis nodularis chronica helicis on the antihelix in an elderly woman. Int J Dermatol 2010 0.76
306 Tacrolimus ointment: utilization patterns in children under age 2 years. Dermatol Online J 2004 0.76
307 Psoriasis during pregnancy: characteristics and important management recommendations. Expert Rev Clin Immunol 2015 0.76
308 Psoriasis and cardiovascular screening rates in the United States. J Drugs Dermatol 2013 0.76
309 Common skin disorders seen in the migrant farmworker health care clinic setting. J Agromedicine 2007 0.76
310 The role of commercial tanning beds and ultraviolet A light in the treatment of psoriasis. J Dermatolog Treat 2005 0.76
311 What's new in the topical treatment of allergic skin diseases. Curr Opin Allergy Clin Immunol 2014 0.76
312 Remissions of psoriasis with excimer laser treatment. J Drugs Dermatol 2002 0.76
313 Prescribing patterns for topical retinoids within NAMCS data. J Drugs Dermatol 2005 0.75
314 Tattooing practices in the migrant Latino farmworker population: risk for blood-borne disease. Int J Dermatol 2009 0.75
315 Radiofrequency heating for striae: does it work? J Dermatolog Treat 2009 0.75
316 Commentary on Cost of Actinic Keratoses and Skin Cancers. Dermatol Surg 2016 0.75
317 Treatment sequencing after failure of the first biologic in cost-effectiveness models of psoriasis: a systematic review of published models and clinical practice guidelines. Pharmacoeconomics 2014 0.75
318 Patterns of disease and treatment of cold sores. J Dermatolog Treat 2013 0.75
319 Pitfalls of frozen section biopsy. Dermatol Surg 2010 0.75
320 Let's not presuppose that patients take their medications. J Dermatolog Treat 2012 0.75
321 Recruiting underserved mothers to medical research: findings from North Carolina. J Health Care Poor Underserved 2013 0.75
322 Importance of providing adequate patient information to ensure good adherence and outcomes: comment on "Efficacy of an educational intervention with kidney transplant recipients to promote skin self-examination for squamous cell carcinoma detection". Arch Dermatol 2011 0.75
323 Misunderstandings. J Dermatolog Treat 2007 0.75
324 Placebo response? Psychosom Med 2010 0.75
325 Access to unused health care. South Med J 2010 0.75
326 Teledermatology consultations provide specialty care for farmworkers in rural clinics. J Rural Health 2009 0.75
327 What are patients looking for? MedGenMed 2006 0.75
328 Sun protection strength of a hydroquinone 4%/retinol 0.3% preparation containing sunscreens. J Drugs Dermatol 2006 0.75
329 Ambulatory melanoma care patterns in the United States. J Skin Cancer 2013 0.75
330 A disease of the present: scurvy in "well-nourished" patients. J Am Acad Dermatol 2013 0.75
331 Adherence to Oral and Topical Medications in Cutaneous Lupus Erythematosus is not Well Characterized. Dermatol Ther (Heidelb) 2015 0.75
332 Commentary: we know how much mohs is done, but is it appropriate? Dermatol Surg 2012 0.75
333 Commentary on "gynecomastia: etiologies, clinical presentations, diagnosis, and management". South Med J 2014 0.75
334 The moral of the isotretinoin depression story. J Dermatolog Treat 2004 0.75
335 Practice gap in patient education: comment on "the person-centered dermatology self-care index". Arch Dermatol 2012 0.75
336 Adherence must always be considered: is everolimus really ineffective as a treatment for atopic dermatitis? J Dermatolog Treat 2009 0.75
337 Adherence to treatment: still the forgotten variable. Arch Dermatol 2010 0.75
338 A consideration when interpreting outpatient data. J Am Acad Dermatol 2011 0.75
339 A method to gain a sense of relative efficacy of acne medications that have not yet been studied. J Drugs Dermatol 2007 0.75
340 Dermatologic medication adherence. Dermatol Clin 2009 0.75
341 Commentary: the growing skin cancer problem. Dermatol Surg 2013 0.75
342 Measurement of health-related quality of life (HRQOL) associated with skin disease. J Am Acad Dermatol 2004 0.75
343 Microscopically differentiating dermatophytes from sock fibers. J Am Acad Dermatol 2009 0.75
344 Measure of atopic dermatitis disease severity using actigraphy. J Cutan Med Surg 2013 0.75
345 Cutaneous larva migrans in a migrant Latino farmworker. J Agromedicine 2007 0.75
346 Conversion to positive tuberculosis test during etanercept treatment of psoriasis. J Drugs Dermatol 2007 0.75
347 Prescribing on the basis of subjective disease severity. J Dermatolog Treat 2006 0.75
348 Comparing demographic characteristics and adverse event rates at two dermatologic surgery practices. J Cutan Med Surg 2014 0.75
349 Reaching for better understanding across the globe. J Dermatolog Treat 2012 0.75
350 Principles of topical treatment: advancement in gel vehicle technology. J Drugs Dermatol 2014 0.75
351 Gel vehicles are not inherently more irritating than creams. J Drugs Dermatol 2006 0.75
352 Context and contrast. J Dermatolog Treat 2008 0.75
353 Hypothyroidism in Patients with Psoriasis or Rosacea: A Large Population Study. Dermatol Online J 2016 0.75
354 Efficacy of low-dose acitretin in the treatment of psoriasis. J Dermatolog Treat 2011 0.75
355 Limited availability of psoriasis and phototherapy care: an analysis of advertisements. Dermatol Online J 2005 0.75
356 Web app based patient education in psoriasis - a randomized controlled trial. Dermatol Online J 2017 0.75
357 Costs of Common Psoriasis Medications, 2010-2014. J Drugs Dermatol 2016 0.75
358 Considerable variation among Iranian dermatologists in the dosing and monitoring of methotrexate for treating psoriasis. Int J Dermatol 2013 0.75
359 Adapting electronic adherence monitors to standard packages of topical medications. J Am Acad Dermatol 2006 0.75
360 Is the duration of skin disease visits decreasing in the United States? Dermatol Online J 2014 0.75
361 Psoriasis and its treatment with adalimumab. Expert Opin Biol Ther 2010 0.75
362 Where has Goeckerman treatment gone? J Dermatolog Treat 2005 0.75
363 Patient perceptions of text-messages, email, and video in dermatologic surgery patients. Dermatol Online J 2017 0.75
364 Rosacea in skin of color: not a rare diagnosis. Dermatol Online J 2014 0.75
365 Detecting adverse events in dermatologic surgery. Dermatol Surg 2009 0.75
366 Measuring patient satisfaction changes patient satisfaction. J Dermatolog Treat 2012 0.75
367 Dermatologists as surgeons. Dermatol Surg 2003 0.75
368 A dermatologist's dilemma: treatment failure or failure to treat? Cutis 2012 0.75
369 Is concomitant use of methotrexate and oral retinoids dangerous? A review of the data regarding this combination. J Am Acad Dermatol 2011 0.75
370 Use of transcutaneous nerve stimulation wristband to treat methotrexate-induced nausea. J Cutan Med Surg 2002 0.75
371 Why don't patients get better? The three 'nons'. J Dermatolog Treat 2007 0.75
372 Efficacy, safety, and cost of office-based surgery: a multidisciplinary perspective. Dermatol Surg 2003 0.75
373 Keratolytics for psoriasis: are they necessary? Dermatol Online J 2009 0.75
374 Physician performance measures in dermatology. J Am Acad Dermatol 2010 0.75
375 Common use of prescription off-label acne therapy in children younger than 12 years old. Pediatr Dermatol 2014 0.75
376 Spanish dermatological vocabulary used by Mexican workers. Dermatol Online J 2005 0.75
377 Message from the guest editor. J Drugs Dermatol 2012 0.75
378 Indoor tanning relieves pain. Photodermatol Photoimmunol Photomed 2005 0.75
379 Literature is lacking in discussion of non-adherence in dermatology. J Dermatolog Treat 2010 0.75
380 The distress of psoriasis doesn't necessarily imply good treatment adherence: a lesson from the treatment of sexually transmitted disease. J Dermatolog Treat 2008 0.75
381 Letter: Tetracycline-induced hepatotoxicity. Dermatol Online J 2011 0.75
382 Are corticosteroids effective for prevention of scar formation after second-degree skin burn? J Dermatolog Treat 2013 0.75
383 Predicting improvement in signs and symptoms of plaque psoriasis after 1 week of treatment with clobetasol propionate 0.05% spray. J Drugs Dermatol 2013 0.75
384 Perhaps programs are a better way to go. J Dermatolog Treat 2010 0.75
385 Seasonal variations in dermatology manuscript submission. J Dermatolog Treat 2010 0.75
386 Treatment of impetigo: oral antibiotics most commonly prescribed. J Drugs Dermatol 2012 0.75
387 Surveillance and assessment of occupational dermatitis using Rhode Island workers' compensation data 1998 to 2002. J Am Acad Dermatol 2006 0.75
388 The continued evolution of drugs for psoriasis. J Drugs Dermatol 2013 0.75
389 Treatment of Atopic Dermatitis in the United States: Analysis of Data from the National Ambulatory Medical Care Survey. J Drugs Dermatol 2017 0.75
390 Low-dose acitretin is associated with fewer adverse events than high-dose acitretin in the treatment of psoriasis. Arch Dermatol 2006 0.75
391 Biologic therapy for psoriasis: telephone triage. Dermatol Nurs 2005 0.75
392 A practice brochure: complement to, not supplement for, good physician-patient interaction. Arch Dermatol 2007 0.75
393 Zebrafish for modeling skin disorders. Dermatol Online J 2016 0.75
394 Analysis of a New York Times article on the public's perception of dermatologists. JAMA Dermatol 2014 0.75
395 Timing of return office visit affects adherence to topical treatment in patients with atopic dermatitis: an analysis of 5 studies. Cutis 2013 0.75
396 Department of Dermatology was blessed with a wonderful psoriasis specialist. Foreword. BioDrugs 2013 0.75
397 Noncosmetic skin-related procedures performed in the United States: an analysis of national ambulatory medical care survey data from 1995 to 2010. Dermatol Surg 2013 0.75
398 Management of psoriasis. South Med J 2009 0.75
399 What the National Psoriasis Foundation means to dermatologists and our patients. Cutis 2008 0.75
400 Medication use and associated health care outcomes and costs for patients with psoriasis in the United States. J Dermatolog Treat 2011 0.75
401 Biologics and biosimilars. J Dermatolog Treat 2015 0.75
402 Outcomes associated with the use of biologic agents in moderate to severe psoriasis. J Drugs Dermatol 2007 0.75
403 Dyschromia in skin of color. J Drugs Dermatol 2014 0.75
404 An educational brochure helps improve patients' understanding of residents' role and level of training. J Am Acad Dermatol 2007 0.75
405 Treatment failure of patients using topical acne treatments: an observational retrospective cohort study. J Dermatolog Treat 2014 0.75
406 Many new options for improving patients' care. J Dermatolog Treat 2009 0.75
407 We must think outside the box to understand nonadherence. Pediatr Dermatol 2011 0.75
408 Patient perspectives on low level light therapy and laser therapies for rosacea-associated persistent facial redness. Dermatol Online J 2014 0.75
409 The extent of dermatopathology education: a comparison of pathology and dermatology. J Am Acad Dermatol 2005 0.75
410 Managing rosacea: a review of the use of metronidazole alone and in combination with oral antibiotics. J Drugs Dermatol 2007 0.75
411 Tazarotene cream (0.1%) in combination with betamethasone valerate foam (0.12%) for plaque-type psoriasis. J Drugs Dermatol 2005 0.75
412 Case report: Fluocinonide-induced perioral dermatitis in a patient with psoriasis. Dermatol Online J 2009 0.75
413 The frequent use of oral retinoids in combination with other treatments for psoriasis: a retrospective analysis. J Cutan Med Surg 2005 0.75
414 Prevalence of psoriasis and rosacea comorbidities in the outpatient setting. J Cutan Med Surg 2013 0.75
415 What you should do when people don't get well. J Dermatolog Treat 2007 0.75
416 Is Safety Psoriasis Patients' Overriding Concern? J Cutan Med Surg 2015 0.75
417 Health insurance benefit limits: general concepts and the potential impact on dermatologic treatment. J Am Acad Dermatol 2005 0.75
418 Skin manifestations of outpatient adverse drug events in the United States: a national analysis. J Cutan Med Surg 2013 0.75
419 Dermatological patient safety: problems and solutions. J Dermatolog Treat 2010 0.75
420 The rosacea patient journey: a novel approach to conceptualizing patient experiences. Cutis 2015 0.75
421 Are ointments better than other vehicles for corticosteroid treatment of psoriasis? J Drugs Dermatol 2009 0.75
422 New Frontiers in Psoriasis Treatment. J Drugs Dermatol 2015 0.75
423 Acitretin for the treatment of psoriasis: an assessment of national trends. J Drugs Dermatol 2011 0.75
424 Improving medication adherence through technology: analyzing the managing meds video challenge. Skin Res Technol 2013 0.75
425 Patient satisfaction in dermatology: a qualitative assessment. Dermatol Online J 2014 0.75
426 Topical Desoximetasone 0.25% Spray and Its Vehicle Have Little Potential for Irritation or Sensitization. J Drugs Dermatol 2017 0.75
427 Dermpath-l: a professional electronic mailing list for dermatopathology. J Cutan Pathol 2009 0.75
428 Isotretinoin and oral contraceptive use in female acne patients varies by physician specialty: analysis of data from the National Ambulatory Medical Care Survey. J Dermatolog Treat 2012 0.75
429 Psoriasis: the new and the old. J Drugs Dermatol 2014 0.75
430 Resident education: effect of the sixth national psoriasis foundation chief residents' meeting. J Cutan Med Surg 2007 0.75
431 Cryo-Induced Thermal Wounds: A Human Acute Wound Model. J Drugs Dermatol 2015 0.75
432 Cumulative irritation potential of metronidazole gel compared to azelaic acid gel after repeated applications to healthy skin. J Drugs Dermatol 2005 0.75
433 Long-term safety of ketoconazole foam, 2% in the treatment of seborrheic dermatitis: results of a phase IV, open-label study. J Drugs Dermatol 2013 0.75
434 Psoriasis treatments by payment type in the US outpatient office setting. J Drugs Dermatol 2013 0.75
435 The rise of the generic drug market and its implications for dermatology. J Dermatolog Treat 2005 0.75
436 US dermatopathology fellows career survey: 2004-2005. J Cutan Pathol 2007 0.75
437 How often do pharmacology textbooks address medication adherence? J Dermatolog Treat 2015 0.75
438 Follow-up survey of 308-nm laser treatment of psoriasis. Lasers Surg Med 2002 0.75
439 Infliximab for inpatient psoriasis management--is there a role? J Dermatolog Treat 2005 0.75
440 Onychomycosis treatment in the United States. Cutis 2015 0.75
441 Transcending the language barrier--creation of a multilingual dermatology website. Dermatol Online J 2007 0.75
442 Adherence to topical hydrocortisone 17-butyrate 0.1% in different vehicles in adults with atopic dermatitis. J Am Acad Dermatol 2009 0.75
443 Five-Year Trend in the Number of Dermatologic Clinical Drug Trials Registered on ClinicalTrials.gov. J Drugs Dermatol 2015 0.75
444 Dermatology Residents are Prescribing Tanning Bed Treatment. Dermatol Online J 2016 0.75
445 Off-label prescribing in the treatment of dermatologic disease. J Am Acad Dermatol 2002 0.75
446 A Randomized, Double-Blind, Placebo-Controlled Study of the Vasoconstrictor Potency of Topical 0.25% Desoximetasone Spray: A High to Super High Range of Potency (Class I to Class II) Corticosteroid Formulation. J Drugs Dermatol 2017 0.75
447 Targeted UV therapy in the treatment of psoriasis. J Dermatolog Treat 2008 0.75
448 Analysis of factors associated with prescription of a potentially inappropriate combination dermatological medication among US outpatient physicians. Pharmacoepidemiol Drug Saf 2004 0.75
449 Services available and their effectiveness. Dermatol Clin 2012 0.75
450 Nondermatologist physicians advertising the provision of skin care services. J Am Acad Dermatol 2011 0.75
451 The importance of avoiding electrosurgical artifact at the margins of melanoma excisions. J Surg Oncol 2007 0.75
452 Topical clobetasol in conjunction with topical tretinoin is effective in preventing scar formation after superficial partial-thickness burn ulcers of the skin: A retrospective study. J Dermatolog Treat 2014 0.75
453 Acitretin prescribing patterns in women of childbearing potential. J Drugs Dermatol 2013 0.75
454 Dermatologists: Collaborating With Payers to Optimize Coverage Policies. J Drugs Dermatol 2017 0.75
455 Systemic corticosteroids are frequently prescribed for psoriasis. J Cutan Med Surg 2014 0.75
456 Tattoo sites and psoriasis. J Drugs Dermatol 2011 0.75
457 What are the most important factors that determine the overall quality of dermatology residency training: A resident survey. Dermatol Online J 2015 0.75
458 Trends in on and off-label calcipotriene use. J Dermatolog Treat 2006 0.75
459 Patients are often terrified of treatments. J Dermatolog Treat 2013 0.75
460 Factors associated with topical retinoid prescriptions for acne. J Dermatolog Treat 2014 0.75
461 Are patients willing to participate in surveys? J Dermatolog Treat 2014 0.75
462 The duration of acne treatment. J Drugs Dermatol 2014 0.75
463 Dictation templates improve coding accuracy in an academic dermatology practice. J Am Acad Dermatol 2006 0.75
464 Reappraising the phototoxicity of tretinoin: a report of four controlled clinical trials. Photodermatol Photoimmunol Photomed 2009 0.75
465 Most common dermatologic conditions encountered by dermatologists and nondermatologists. Cutis 2014 0.75
466 Treatments for mild-to-moderate recalcitrant plaque psoriasis: expected clinical and economic outcomes for first-line and second-line care. Dermatol Online J 2005 0.75
467 Monitoring for medication errors in outpatient settings. J Dermatolog Treat 2009 0.75
468 'Coral reef' psoriasis: a marker of resistance to topical treatment. J Dermatolog Treat 2008 0.75
469 Quantifying and characterizing adverse events in dermatologic surgery. Dermatol Surg 2013 0.75
470 Topical antibiotic trends from 1993 to 2007: use of topical antibiotics for non-evidence-based indications. Dermatol Surg 2011 0.75
471 Efficacy of cryosurgery and 5-fluorouracil cream 0.5% combination therapy for the treatment of actinic keratosis. Cutis 2014 0.75
472 Tanning beds as an alternative for psoriasis when office-based phototherapy is not accessible. J Dermatolog Treat 2009 0.75
473 Decreasing frequency of office visits on fridays. J Dermatolog Treat 2013 0.75
474 Factors affecting prescription of ultra-high potency topical corticosteroids in skin disease: an analysis of US national practice data. J Drugs Dermatol 2005 0.75
475 Usage of complementary and alternative medicine for management of skin disease. J Dermatolog Treat 2011 0.75
476 Equating topical treatment of severe psoriasis to keeping money in a mattress. J Dermatolog Treat 2009 0.75
477 The utility of a data-logging device for measuring adherence to home phototherapy. Photodermatol Photoimmunol Photomed 2006 0.75
478 Timing of office visits can be a powerful tool to improve adherence in the treatment of dermatologic conditions. J Dermatolog Treat 2013 0.75
479 Terbinafine is more effective than itraconazole in treating toenail onychomycosis: results from a meta-analysis of randomized controlled trials. J Cutan Med Surg 2004 0.75
480 Real-World Effectiveness and Safety of Field- and Lesion-Directed Treatments for Actinic Keratosis. J Drugs Dermatol 2020 0.75
481 No smoking gun: findings from a national survey of office-based cosmetic surgery adverse event reporting. Dermatol Surg 2003 0.75
482 Are wash outs needed in clinical trials of topical agents? J Dermatolog Treat 2014 0.75
483 A Medicare cost comparison of minor cutaneous procedures by surgical setting. J Dermatolog Treat 2010 0.75
484 Over-the-counter topical skin products--a common component of skin disease management. Cutis 2004 0.75
485 Horrendous, Treatment-resistant Pediatric Atopic Dermatitis Solved With a Change in Vehicle. J Drugs Dermatol 2016 0.75
486 Not French manicure but onycholysis. Dermatol Online J 2014 0.75
487 Explicit and implicit copayments for phototherapy: examining the cost of commuting. Dermatol Online J 2013 0.75
488 Trends in the use of topical over the counter products in the management of dermatologic disease in the United States. Dermatol Online J 2012 0.75
489 The National Ambulatory Medical Care Survey: a resource for understanding the outpatient dermatology treatment. J Dermatolog Treat 2013 0.75
490 Eyeglass allergic contact dermatitis. Dermatol Online J 2010 0.75
491 Nonlaser UVB-targeted phototherapy treatment of psoriasis. Cutis 2006 0.75
492 The clinical triage assistant: a new member of the dermatology health care team. J Am Acad Dermatol 2010 0.75
493 Treatment of moderate-to-severe psoriasis with alefacept for up to one year: a case series. J Drugs Dermatol 2010 0.75
494 Comparison of different compliance behaviors in a clinical trial. Cutis 2007 0.75
495 Focusing and depth of field in photography: application in dermatology practice. Skin Res Technol 2013 0.75
496 Evolution in psoriasis management. J Dermatolog Treat 2017 0.75
497 Nonmelanoma skin cancer treatment training varies across different medical specialists. J Dermatolog Treat 2013 0.75
498 Lack of information in current guidelines regarding systemic corticosteroids in inflammatory diseases. Dermatol Online J 2014 0.75
499 Can light-field photography ease focusing on the scalp and oral cavity? Skin Res Technol 2013 0.75
500 Improvement in severe psoriasis associated with isoniazid treatment. Dermatol Online J 2014 0.75
501 Cost-effectiveness analysis of using dermatologists versus pediatricians to treat mild to moderate acne. Dermatol Online J 2017 0.75
502 Intermittent dosing of biologics for psoriasis. J Dermatolog Treat 2006 0.75